Clene Inc. Common Stock (CLNN) is a publicly traded Healthcare sector company. As of May 21, 2026, CLNN trades at $6.72 with a market cap of $86.76M and a P/E ratio of -1.19. CLNN moved +7.60% today. Year to date, CLNN is +19.79%; over the trailing twelve months it is +165.38%. Its 52-week range spans $2.28 to $13.50. Analyst consensus is strong buy with an average price target of $32.20. Rallies surfaces CLNN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CLNN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CLNN recently traded at $6.72. Market cap is $86.76M. P/E ratio is -1.19. Revenue is $342.00K.
| Metric | Value |
|---|---|
| Price | $6.72 |
| Market Cap | $86.76M |
| P/E Ratio | -1.19 |
| EPS | $-5.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.50 |
| 52-Week Low | $2.28 |
| Volume | 201 |
| Avg Volume | 0 |
| Revenue (TTM) | $342.00K |
| Net Income | $-39.40M |
| Gross Margin | 79.53% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2024 | $342.00K | $-39.40M | $-5.67 |
| 2023 | $654.00K | $-49.50M | $-0.47 |
| 2022 | $473.00K | $-29.92M | $-0.46 |
| 2021 | $723.00K | $-9.74M | $0.00 |
5 analysts cover CLNN: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $32.20.